Evidence map›Paper›PMID 25625511›Full record

ArticleInternational journal of molecular sciences2015

EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.

Chih-Yeu Fang, Chung-Chun Wu, Hui-Yu Hsu, Hsin-Ying Chuang, Sheng-Yen Huang, Ching-Hwa Tsai, Yao Chang, George Sai-Wah Tsao, Chi-Long Chen, Jen-Yang Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Chih-Yeu FangDepartment of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan. phildts@gmail.com.
Chung-Chun WuNational Institute of Cancer Research, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan. chungcwu@nhri.org.tw.
Hui-Yu HsuNational Institute of Cancer Research, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan. kakacoco0218@gmail.com.
Hsin-Ying ChuangNational Institute of Cancer Research, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan. tw.hitomi@gmail.com.
Sheng-Yen HuangNational Institute of Cancer Research, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan. syhuang@nhri.org.tw.
Ching-Hwa TsaiDepartment of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan. chtsai@ntu.edu.tw.
Yao ChangNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan 701, Taiwan. yaochang@nhri.org.tw.
George Sai-Wah TsaoDepartment of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. gswtsao@hkucc.hku.hk.
Chi-Long ChenDepartment of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan. chencl@tmu.edu.tw.
Jen-Yang ChenNational Institute of Cancer Research, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan. cjy@nhri.org.tw.
National Health Research Institutes · TWNational Taiwan University · TWNational Tsing Hua University · TWTaipei Medical University · TWUniversity of Hong Kong · HKWan Fang Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(-)-Epigallocatechin-3-gallate (EGCG), a major green tea polyphenol, has been shown to inhibit the proliferation of a variety of tumor cells. Epidemiological studies have shown that drinking green tea can reduce the incidence of nasopharyngeal carcinoma (NPC), yet the underlying mechanism is not well understood. In this study, the inhibitory effect of EGCG was tested on a set of Epstein Barr virus-negative and -positive NPC cell lines. Treatment with EGCG inhibited the proliferation of NPC cells but did not affect the growth of a non-malignant nasopharyngeal cell line, NP460hTert. Moreover, EGCG treated cells had reduced migration and invasive properties. The expression of the cell adhesion molecules E-cadherin and β-catenin was found to be up-regulated by EGCG treatment, while the down-regulation of matrix metalloproteinases (MMP)-2 and MMP-9 were found to be mediated by suppression of extracellular signal-regulated kinase (ERK) phosphorylation and AP-1 and Sp1 transactivation. Spheroid formation by NPC cells in suspension was significantly inhibited by EGCG. Oral administration of EGCG was capable of suppressing tumor growth in xenografted mice bearing NPC tumors. Treatment with EGCG was found to elevate the expression of p53 and p21, and eventually led to apoptosis of NPC cells via caspase 3 activation. The nuclear translocation of NF-κB and β-catenin was also suppressed by EGCG treatment. These results indicate that EGCG can inhibit the proliferation and invasiveness, and induce apoptosis, of NPC cells, making it a promising agent for chemoprevention or adjuvant therapy of NPC.

Indexed as

AnimalsApoptosisCadherinsCarcinomaCaspase 3CatechinCell Adhesion MoleculesCell Line, TumorCell MovementCell ProliferationDown-RegulationExtracellular Signal-Regulated MAP KinasesGelatinasesHumansMiceMice, SCIDCadherinsCaspase 3CatechinCell Adhesion Moleculesepigallocatechin gallateExtracellular Signal-Regulated MAP KinasesGelatinasesNF-kappa B

Identifiers

PMID25625511
PMCPMC4346850
OpenAlexW2015463086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.